The Award

The Canadian Cardiovascular Society (CCS) is pleased to launch the 2018 CCS Atrial Fibrillation Research Award. Entering its fourth year, this important research funding initiative encourages clinical, health services and population health research in the field of atrial fibrillation (AF). Applicants must be CCS members to be eligible to apply.

Nearly 350,000 Canadians have AF. Affecting 1 in 4 adults over the age of 40, this widespread form of arrhythmia puts patients at an increased risk of stroke. Strokes caused by AF can have devastating consequences for patients and their families, greatly affecting the quality of life of many Canadians. Given its prevalence and potential risks, AF has become a dominant concern for Canadians and health professionals in the field of cardiovascular care.

Priority research areas for the 2018 edition of the CCS AF Research Award focus on advancing knowledge and practices in AF care, including the following:

    • Improving diagnosis of AF
    • Managing AF and improving patient care
    • Preventing stroke in AF
    • Improving knowledge about and care for special populations with AF

The 2018 CCS AF Research Award submission is now closed.


Bristol Myers Squibb Pfizer Logo transparent background